TLX1 and leukemia: To this aim, we injected PD-TALL8 (TLX1) in NOD/SCID mice (n=8/9 mice per group), and when mice developed full-blown leukemia (as defined above), they were treated for 5 consecutive days with Givinostat or vehicle.